Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Solid Tumor Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00449280
What this trial is testing

Drug Interaction Study of Sorafenib and Rapamycin in Advanced Malignancies

Who this might be right for
Advanced Solid Tumor
University of Chicago 34
Very early researchNot Yet RecruitingNCT07342738
What this trial is testing

TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors

Who this might be right for
KRAS G12VKRAS G12DSolid Tumor
Sun Yat-sen University 25
Not applicableUnknownNCT04579978
What this trial is testing

Tumor Immunotherapy and Microbiome Analysis

Who this might be right for
Advanced Solid Tumor
Sunnybrook Health Sciences Centre 60
Early research (Phase 1)UnknownNCT05787535
What this trial is testing

HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor

Who this might be right for
Cervical CancerHead and Neck Squamous Cell CarcinomaOropharyngeal Cancer+4 more
HRYZ Biotech Co. 17
Early research (Phase 1)Study completedNCT00426140
What this trial is testing

Pharmacokinetics of Patupilone After a Single Intravenous Administration in Patients With Advance Solid Tumor Malignancies.

Who this might be right for
Advanced MalignanciesSolid Tumors
Novartis Pharmaceuticals 5
Testing effectiveness (Phase 2)Looking for participantsNCT05150691
What this trial is testing

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

Who this might be right for
HER2-positive Advanced Solid Tumor
DualityBio Inc. 796
Early research (Phase 1)UnknownNCT05836623
What this trial is testing

A Phase I Study to Assess PSMA+ and PSMA- Tumour Lesions

Who this might be right for
Advanced and/or Metastatic Solid Tumours
Crescendo Biologics Ltd. 5
Early research (Phase 1)Study completedNCT00290680
What this trial is testing

Bortezomib and Celecoxib in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Medical University of South Carolina 36
Testing effectiveness (Phase 2)Study completedNCT03261947
What this trial is testing

Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors

Who this might be right for
Metastatic Pancreatic CancerColorectal CancerEsophageal Neoplasms+1 more
Millennium Pharmaceuticals, Inc. 101
Early research (Phase 1)Study completedNCT03218826
What this trial is testing

PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Advanced Breast CarcinomaAdvanced Malignant Solid NeoplasmAdvanced Prostate Carcinoma+23 more
National Cancer Institute (NCI) 23
Early research (Phase 1)Looking for participantsNCT07300150
What this trial is testing

PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors

Who this might be right for
Colorectal CancerPancreatic CancerNon-Small Cell Lung Cancer+1 more
PAQ Therapeutics, Inc. 210
Early research (Phase 1)UnknownNCT05982080
What this trial is testing

Investigate FP002 in Subjects With Advanced Malignancies

Who this might be right for
Advanced Solid Tumor
Guangdong Fapon Biopharma Inc. 27
Testing effectiveness (Phase 2)Study completedNCT02697591
What this trial is testing

INCAGN01876 in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced MalignanciesMetastatic Cancer
Incyte Biosciences International Sàrl 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07723482
What this trial is testing

ML-016 in Advanced Cancer With Lung and/or Liver Involvement

Who this might be right for
Advanced Solid Tumor With Lung and/or Liver Involvement
BrYet US, Inc. 108
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07631884
What this trial is testing

Exploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid Tumor

Who this might be right for
Solid TumorsNeoplasms (Cancer / Tumors)Advanced Malignant Solid Neoplasm+13 more
Haihua Yuan 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT06205706
What this trial is testing

BI-1910 as a Single Agent and in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors

Who this might be right for
Solid TumorsNon Small Cell Lung CancerHepatocellular Carcinoma
BioInvent International AB 35
Testing effectiveness (Phase 2)Study completedNCT00264004
What this trial is testing

Study to Investigate the Management of Hypertension and Efficacy of AZD2171 in Patients With Advanced Solid Tumours

Who this might be right for
Tumors
AstraZeneca 119
Early research (Phase 1)Study completedNCT00712504
What this trial is testing

Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer

Who this might be right for
Advanced Solid TumorsNon Small Cell Lung Cancer
Pfizer 49
Not applicableEnded earlyNCT05477784
What this trial is testing

Cancer Parenting Program for the Enhancement of the Quality of Life of Patients With Advanced Cancer and Their Children

Who this might be right for
Parent-Child RelationsCancerSurvivorship+4 more
University of Washington 174
Testing effectiveness (Phase 2)Study completedNCT01827384
What this trial is testing

MPACT Study to Compare Effects of Targeted Drugs on Tumor Gene Variations

Who this might be right for
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI) 208
Next Page